MYO

Myomo
AMEX

Real-time Quotes | Nasdaq Last Sale

4.460
+0.160
+3.72%
After Hours: 4.200 -0.26 -5.83% 17:16 09/24 EDT
OPEN
4.220
PREV CLOSE
4.300
HIGH
4.500
LOW
4.120
VOLUME
363.95K
TURNOVER
--
52 WEEK HIGH
40.00
52 WEEK LOW
2.820
MARKET CAP
16.38M
P/E (TTM)
-0.3348
1D
5D
1M
3M
1Y
5Y
News
Financial
Releases
Corp Actions
Analysis
Profile
INO, BKR, KODK and AHT among after-hours movers
Gainers: [[JAX]] +14%. [[KZR]] +10.3%. [[AHT]] +8%. [[KODK]] +7.9%. [[OM]] +5%.Losers: [[INO]] -3.8%. [[BTU]] -3.7%. [[EPRT]] -3.2%. [[BKR]] -3%. [[MYO]] -2.8%.
Seekingalpha · 09/17 21:44
Arrowhead Pharmaceuticals, Myomo leads healthcare gainers, Novus Therapeutics, Jounce Therapeutics among major losers
Gainers: Arrowhead Pharmaceuticals (ARWR) +46%, Myomo (MYO) +38%, AxoGen (AXGN) +15%, Covetrus (CVET) +14%, Inovio Pharmaceuticals (INO) +13%.Losers: Novus Therapeutics (NVUS) -13%, Jounce Therapeutics (JNCE) -10%, Syneos Health (SYNH) -7%, Verastem (VSTM) -5%, Evogene (EVGN) -5%.
Seekingalpha · 09/16 15:00
Mid-Morning Market Update: Markets Open Higher; FedEx Tops Q1 Expectations
Following the market opening Wednesday, the Dow traded up 0.42% to 28111.93 while the NASDAQ rose 0.03% to 11193.23. The S&P also rose, gaining 0.29% to 3,410.98.
Benzinga · 09/16 14:19
MYO, FDX, NKLA and VERI among after-hours movers
Gainers: [[MYO]] +64.9%. [[AMCX]] +16.5%. [[INO]] +8.9%. [[FDX]] +8.8%. [[FWONA]] +8.7%.Losers: [[NKLA]] -6.1%. [[STSA]] -5.4%. [[SPWH]] -5.0%. [[VERI]] -4.5%. [[MRNS]] -3.8%.
Seekingalpha · 09/15 21:40
Myomo Certified as Medicare Provider
Myomo, Inc. (NYSE American: MYO) ("Myomo" or the "Company"), a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper-limb paralysis, today announced that the Centers for Medicare & Medicaid Services under the
Business Wire · 09/15 21:05
Myomo® to Present at the H.C. Wainwright Virtual 22nd Annual Global Investment Conference
Business Wire · 09/10 13:30
Myomo, Inc. to Present at The LD 500 Virtual Conference
LOS ANGELES, CA / ACCESSWIRE / August 26, 2020 / Myomo, Inc.
ACCESSWIRE · 08/26 21:05
Myomo® Extends and Strengthens its Global MyoPro Patent Portfolio
Myomo, Inc. (NYSE American: MYO) ("Myomo" or the "Company"), a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper-limb paralysis, today announced additional intellectual property protection with the issuance
Business Wire · 08/26 11:00
More
Forecast
EPSBVPSCFPS
Actual (K USD)
Estimate (K USD)
Income StatementMore
Net IncomeTotal RevenueOperating Income
Net Income (USD)
YoY (%)
Balance SheetMore
Total Assets (USD)
Total Liabilities (USD)
Debt to Asset (%)
Cash FlowMore
OperatingInvestingFinancing
Operating (USD)
YoY (%)
Learn about the latest financial forecast of MYO. Analyze the recent business situations of Myomo through EPS, BVPS, FPS, and other data. This information may help you make smarter investment decisions.
Analyst Rating

Based on 3 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target
The average MYO stock price target is 9.25 with a high estimate of 13.00 and a low estimate of 5.00.
EPS
Institutional Holdings
Institutions: 16
Institutional Holdings: 1.72M
% Owned: 46.97%
Shares Outstanding: 3.67M
TypeInstitutionsShares
Increased
5
181.43K
New
2
182.53K
Decreased
3
53.28K
Sold Out
7
253.27K
  • Performance
  • Asset Allocation
  • Dividend History
No Data
Industry
Medical Equipment, Supplies & Distribution
-0.71%
Healthcare Equipment & Supplies
-0.59%
Key Executives
Chairman/President/Founder/Chief Operating Officer/Director
Steve Kelly
Chief Executive Officer/Director
Paul Gudonis
Chief Financial Officer/Chief Accounting Officer
David Henry
General Manager
Jonathan Naft
Other
Fredrick Nahm
  • Dividends
  • Splits
  • Insider Activity
No Data
Access Level 2 Advance
Nasdaq TotalView
for Free
Get Now
About MYO
Myomo, Inc. is a United States-based medical device company specializing in myoelectric orthotics for people with neurological disorders. The Company’s products help to restore function in individuals with neuromuscular conditions, such as brachial plexus injury, spinal cord injury, multiple sclerosis and stroke. Its MyoPro myoelectric limb orthosis is a powered brace that supports a weakened and deformed arm for functional use. The MyoPro is an elbow/wrist/Hand orthosis, which supports the arm and helps to bend and straighten the arm at the elbow. The brace provides assistive function for joint motion that enables a user to self-initiate and control movements of a partially paralyzed arm using their own muscle signals. When the user tries to bend their arm, sensors in the brace detect the weak muscle signal, which activates the motor to amplify their weak muscle signal to help bend and move their arm. The brace uses non-invasive skin sensors.
More
Hot Stocks
Symbol
Price
%Change

Webull offers kinds of Myomo Inc stock information, including AMEX:MYO real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, MYO stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading MYO stock methods without spending real money on the virtual paper trading platform.